Trial
NCT00633776
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
Dey, L.P.
Condition
Chronic Obstructive Pulmonary Disease
Intervention
formoterol fumarate
Why stopped
Sponsor withdrew funding prior to study initiation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-04